Our study delineated the CYP1B1-USP5-HIF2α signalling cascade as a critical resistance mechanism and thus reveals a targetable vulnerability in treatment-refractory ccRCC. Here, CYP1B1 is linked to nonpapillary renal cell carcinoma.